Top Biotechnology Startups in Australia (2025 Update)
Explore the best Biotechnology companies in Australia. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hey there! Bounce Watch here — I'm gathering key information from Top Biotechnology Startups in Australia list.
Real-Time Scouting Assistant

Explore Top Biotechnology Startups in Australia featuring 173 Companies
|
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nutromics | - | We exist to save millions of lives through continuous diagnostic monitoring | Nutromics is an Australian-born diagnostic company with a vision to create a wor... | - |
|
Melbourne | Australia (HQ) + 1 | 2017 | Biotechnology, Hardware +3 | [email protected] |
1
Low
|
59
|
1.6K | 1 year ago | Seed | 7 | 28.6M | 9691 | 5 months ago | ||
|
PolyActiva | - | Enabling Drug Delivery from Medical Devices | PolyActiva is an innovative clinical-stage ophthalmology company with a unique p... | - |
|
Melbourne | Australia (HQ) + 1 | 2010 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
24
|
536 | 12 years ago | Series B | 2 | 11.5M | 1069 | 5 months ago | ||
|
Hexima Limited (ASX:HXL) | - | Clinical stage, anti-infectives biotech company developing defensin peptides for... | Hexima is a clinical stage, anti-infectives focused biotechnology company engage... | - |
|
Melbourne | Australia (HQ) | 1998 | Biotechnology | [email protected] |
1
Low
|
7
|
2.2K (10%) | 15 years ago | Debt Financing | 1 | 1.4M | 594 | 1 xl1 ZAb | ||
|
Currus Biologics Pty Ltd | - | Currus Biologics is developing its proprietary BEAT technology to treat solid tu... | Currus Biologics is utilising its proprietary BEAT technology to develop CAR-T c... | - |
|
Melbourne | Australia (HQ) | 2021 | Biotechnology, Health and Wellness | [email protected] |
1
Low
|
6
|
369 (-66%) | 1 year ago | Series Unknown | 2 | 11.4M | 811 | 5 months ago | ||
|
ESN Cleer | - | The Future is Cleer | ESN Cleer is committed to transforming the way we combat specific segments of Ca... | - |
|
Melbourne | Australia (HQ) | 2018 | Biotechnology | [email protected] |
1
Low
|
7
|
185 | 2 years ago | Grant | 6 | 6.9M | 332 | 1 year ago | ||
|
Immuron | - | Immuron is focused on developing and commercialising products for gut mediated d... | Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrat... | - |
|
Melbourne | Australia (HQ) + 1 | 1994 | Biopharma, Biotechnology | [email protected] |
1
Low
|
16
|
517 | 3 years ago | Grant | 3 | 27.5M | 1314 | 5 months ago | ||
|
OccuRx | - | Developing innovative precision therapies for the treatment of inflammatory and... | Developing innovative precision therapies for the treatment of inflammatory and... | - |
|
Melbourne | Australia (HQ) | 2014 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
4
|
1.1K (-27%) | 2 years ago | Series B | 4 | 21.2M | 472 | 1 year ago | ||
|
Tryp Therapeutics | - | Tryp is leading the next wave of psychedelic drug development. | Tryp Therapeutics is a clinical-stage biotechnology company focused on developin... | - |
|
Melbourne | Australia (HQ) | 2019 | Biotechnology | [email protected] |
1
Low
|
9
|
1.2K | 1 year ago | Post Ipo Equity | 5 | 15.5M | 2563 | 5 months ago | ||
|
AdAlta Ltd | - | Targeting untreated diseases using the i-body: a unique drug discovery platform | AdAlta (ASX:1AD) is the pioneer of a novel technology platform that mimics the s... | - |
|
Melbourne | Australia (HQ) | 2007 | Biotechnology, Health Care | - |
1
Low
|
20
|
858 (-55%) | 14 years ago | Series A | 1 | 3.0M | 1978 | 5 months ago | ||
|
Cartherics Pty Ltd | - | Rearming the body’s immune system to fight cancer | Cartherics is a biotechnology company focused on developing innovative cancer th... | - |
|
Notting Hill | Australia (HQ) | 2014 | Biotechnology | [email protected] |
1
Low
|
35
|
57979 | - | Undisclosed | - | 20.4M | 3310 | 4 months ago | ||
|
Neuren Pharmaceuticals Li... | - | Neuren is developing two new therapies to treat multiple neurodevelopmental diso... | Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitati... | - |
|
Camberwell | Australia (HQ) | 2004 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
19
|
99160 | - | Post Ipo Equity | - | 21.5M | 2193 | 6 months ago | ||
|
Misti | - | Next-generation lung delivery to protect every vulnerable child and adult from i... | Respiratory diseases such as influenza, COVID-19, and human respiratory syncytia... | - |
|
Melbourne | Australia (HQ) | - | Biotechnology, Health Care | - |
1
Low
|
12
|
411 (315%) | 1 year ago | Pre Seed | 1 | 120.0K | 927 | 5 months ago | ||
|
Artrya Ltd | - | We are changing the way Coronary Heart Disease is diagnosed and treated. | Artrya is an applied artificial intelligence healthcare company that works along... | - |
|
- | Australia (HQ) | 2018 | AI, Biotechnology +2 | [email protected] |
1
Low
|
44
|
741 (-100%) | 4 years ago | Series A | 1 | 15.0M | 3334 | 6 months ago | ||
|
OncoRes Medical | - | Transforming the standard of care in breast cancer surgery. | OncoRes Medical is developing an intraoperative imaging tool that translates the... | - |
|
- | Australia (HQ) | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
37
|
7.9K | 3 years ago | Series A | 6 | 14.2M | 3364 | 5 months ago | ||
|
HaemaLogiX Ltd | - | Focusing on the development and commercialisation of novel immuno-oncology and i... | HaemaLogiX focus is the development and commercialisation of novel immuno-oncolo... | - |
|
- | Australia (HQ) | 2014 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
7
|
424 (3433%) | 3 years ago | Series Unknown | 1 | 10.0M | 724 | 1 year ago | ||
|
Tiny Bright Things | - | See tiny better, do impossible things | Tiny Bright Things makes novel Halo Microscopy products to radically improve the... | - |
|
- | Australia (HQ) | 2020 | Biopharma, Biotechnology +4 | [email protected] |
1
Low
|
6
|
331 (-100%) | 2 years ago | Seed | 3 | 2.0M | 591 | 6 months ago | ||
|
Biotome Pty Ltd | - | Next generation antibody diagnostics | Biotome develops antibody tests using next generation technology and precision i... | - |
|
- | Australia (HQ) | 2017 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
10
|
727 (924%) | 1 year ago | Non Equity Assistance | 3 | 497.0K | 576 | 5 months ago | ||
|
Loam Bio | - | We’re using the world’s smallest organisms to solve the world’s biggest problems... | Loam works with 4.5 billion years of evolution to solve the climate crisis. Micr... | - |
|
- | Australia (HQ) + 1 | 2019 | Agriculture, Biotechnology +1 | [email protected] |
1
Low
|
116
|
242 | 2 years ago | Series B | 4 | 155.0M | 17490 | 5 months ago | ||
|
Psylo | - | Psychedelic-inspired medicine to treat mental illness | Psylo is a drug development company focused on next generation psychedelics; our... | - |
|
- | Australia (HQ) | 2021 | Biotechnology | - |
1
Low
|
27
|
138 | 1 year ago | Seed | 3 | 12.0M | 6871 | 6 months ago | ||
|
Ferronova | - | To give everyone diagnosed with cancer their best chance to become cancer free | Ferronova is an innovative medical device company, which has brought together a... | - |
|
- | Australia (HQ) | 2016 | Biotechnology, Health Care +1 | - |
1
Low
|
14
|
689 (-100%) | 2 years ago | Series B | 5 | 15.3M | 910 | 1 year ago | ||
|
Number 8 bio | - | Changing Feed. Feeding Change. | Number 8 bio is developing innovative solutions capable of reducing ruminant met... | - |
|
- | Australia (HQ) | 2022 | Agriculture, Biotechnology +2 | - |
1
Low
|
13
|
521 (-42%) | 1 year ago | Pre Seed | 2 | 1.8M | 1508 | 5 months ago | ||
|
EnGeneIC | - | First-in-class cyto-immunotherapy platform targeting the tumour directly and lev... | EngeneIC is a biopharmaceutical company focused on developing its proprietary ED... | - |
|
- | Australia (HQ) + 1 | 2001 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
30
|
1.3K (-13%) | 8 years ago | Series Unknown | 5 | 17.0M | 2158 | 5 months ago | ||
|
Implicit Bioscience | - | Implicit Bioscience is developing groundbreaking immunotherapy treatments for se... | Implicit Bioscience is an unlisted public company based in Brisbane and Seattle.... | - |
|
- | Australia (HQ) | 2005 | Biotechnology, Health Care | - |
1
Low
|
12
|
572 (-100%) | 4 years ago | Series Unknown | 6 | 17.0M | 444 | 9 NbC jyK | ||
|
Bionomics Ltd | - | Developing novel drug candidates to transform the lives of patients with anxiety... | Bionomics (Nasdaq: BNOX, ASX:BNO) is a clinical-stage biopharmaceutical developi... | - |
|
- | Australia (HQ) + 1 | 1999 | Biotechnology, Health Care | [email protected] |
1
Low
|
30
|
4.0K (-30%) | 1 year ago | Post Ipo Equity | 7 | 113.6M | 2236 | 3 years ago | ||
|
HealthMatch | - | Connecting People To Revolutionary Drugs And Potential Cures | HealthMatch is a digital health company transforming the way patients connect to... | - |
|
- | Australia (HQ) | 2017 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
24
|
1.5M (15%) | 2 years ago | Series C | 5 | 27.5M | 5809 | 8 months ago | ||
|
Azaneo | - | Electrifying Agriculture | Azaneo develops lightning-fast electric weeding technology. Using only electrons... | - |
|
- | Australia (HQ) | 2022 | Agriculture, Biotechnology | - |
1
Low
|
7
|
979 (-100%) | 1 year ago | Pre Seed | 1 | 1.4M | 735 | 7 months ago | ||
|
Immutep Limited | - | The global leader in developing LAG-3 therapeutics (ASX: IMM, NASDAQ: IMMP) | Immutep is a late-stage clinical biotechnology company developing novel LAG-3 im... | - |
|
- | Australia (HQ) | 1987 | Biotechnology, Health Care +1 | - |
1
Low
|
49
|
275 (-100%) | 11 months ago | Post Ipo Equity | 5 | 108.7M | 4697 | 5 months ago | ||
|
Zelira Therapeutics | - | Zelira Therapeutics (formerly Zelda Therapeutics) is a leading global therapeuti... | Zelira Therapeutics Ltd (formerly Zelda Therapeutics) is a leading global therap... | - |
|
- | Australia (HQ) | 2015 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
12
|
2.0K | 2 years ago | Post Ipo Equity | 2 | 13.2M | 2543 | 5 months ago | ||
|
BiomeBank | - | BiomeBank’s mission is to treat and prevent disease by restoring gut microbial e... | BiomeBank’s mission is to treat and prevent disease by restoring gut microbial e... | - |
|
- | Australia (HQ) + 1 | 2018 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
37
|
10.4K (25%) | 2 years ago | Series Unknown | 1 | 10.7M | 3431 | 6 months ago | ||
|
Telix Pharmaceuticals Lim... | - | Developing theranostics (nuclear medicine) for prostate, kidney, glioblastoma, h... | Telix is a biopharmaceutical company focused on the development and commercialis... | - |
|
- | Australia (HQ) | 2015 | Biotechnology | [email protected] |
1
Low
|
496
|
32.9K (12%) | 10 months ago | Post Ipo Debt | 4 | 494.9M | 43926 | 5 months ago | ||
|
Recce Pharmaceuticals Ltd | - | Recce Pharmaceuticals (ASX:RCE) is pioneering a New Class of Synthetic Anti-Infe... | Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q) is pioneering the development and... | - |
|
- | Australia (HQ) + 3 | 2007 | Biotechnology, Pharmaceutical | - |
1
Low
|
19
|
3.8K (-10%) | 10 months ago | Grant | 3 | 30.0M | 3271 | 5 months ago | ||
|
Celosia Therapeutics | - | Solutions for Neurodegenerative Disease | Celosia Therapeutics is a privately held pre-clinical stage gene therapy company... | - |
|
- | Australia (HQ) | 2022 | Biopharma, Biotechnology | [email protected] |
1
Low
|
5
|
49243 | - | Series A | - | 18.8M | 615 | 5 months ago | ||
|
Imugene Limited | - | Bringing Effective New Treatments And Options To Patients Who Need Them | Imugene is a clinical stage immuno-oncology company developing a range of new an... | - |
|
- | Australia (HQ) | 2013 | Biotechnology, Health Care | - |
1
Low
|
55
|
58775 | - | Post Ipo Equity | - | 70.2M | 7574 | 4 months ago | ||
|
23Strands | - | 23Strands is unlocking the power of your DNA | 23Strands is unlocking new clinical insights from the whole genome, through inte... | - |
|
- | Australia (HQ) | 2018 | AI, Big Data +3 | [email protected] |
1
Low
|
29
|
18734 | - | Grant | - | 5.0M | 746 | 1 year ago | ||
|
Cauldron Ferm | - | Biomanufacturing unlocked. | Founded in 2022, Cauldron is a global biomanufacturer on a mission to realize th... | - |
|
- | Australia (HQ) | 2022 | Biotechnology | - |
1
Low
|
20
|
197 (-100%) | 1 year ago | Series A | 3 | 20.0M | 3514 | 5 months ago | ||
|
Omni Biotech | - | Human Performance Monitoring. Anywhere. Any Device. Any Time. | We build health and performance algorithms that work on all hardware platforms.... | - |
|
- | Australia (HQ) | 2018 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
4
|
663 | 5 months ago | Select | 1 | 300.0K | 392 | 1 year ago | ||
|
Cannaponics Ltd | - | People | Planet | Profits | Cannaponics helps make people's lives better by encouraging social equity for a... | - |
|
- | Australia (HQ) | 2019 | Biotechnology | [email protected] |
1
Low
|
10
|
81841 | - | Equity Crowdfunding | - | 3.5M | 1680 | 11 months ago | ||
|
AdvanCell | - | Changing the Course of Cancer Treatment | AdvanCell is a clinical stage radiopharmaceutical company developing an innovati... | - |
|
- | Australia (HQ) + 4 | 2019 | Biotechnology, Pharmaceutical | - |
1
Low
|
43
|
90298 | - | Series B | - | 14.6M | 3303 | 5 months ago | ||
|
PERKii Targeted Release P... | - | PERKii utilises micro-shield technology for a targeted in-gut release of effecti... |
Get through to your gut with PERKii Targeted Release Probiotics. At PERKii, we... |
- |
|
- | Australia (HQ) | 2016 | Biotechnology, Food and Beverage +1 | [email protected] |
1
Low
|
10
|
46651 | - | Series Unknown | - | 7.0M | 1404 | 8 months ago | ||
|
Clarity Pharmaceuticals | - | Clarity is developing next-generation products to address the growing need for r... | Clarity is a clinical stage radiopharmaceutical company developing next-generati... | - |
|
- | Australia (HQ) | 2010 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
61
|
8.3K (73%) | 7 years ago | Series Unknown | 6 | 9.7M | 10691 | 5 months ago |